Pegvisomant
Pegvisomant is a highly selective growth hormone (GH) receptor antagonist. It is used to treat acromegaly. Unlike dopamine or somatostatin analogs (which inhibit growth hormone secretion), this drug actually blocks the hepatic (GH-mediated) production of insulin like growth factor (IGF-1), which is the main mediator of growth hormone activity.
| Trivial name | GH1 |
| Catalog Number | TP-101CL |
| Alternative Name(s) | Pegvisomant |
| Research Area | Endocrine disorders |
| Molecular Formula | C990H1532N262O300S7 |
| CAS# | 218620-50-9 |
| Purity | >90% |
| Size | 1 mg |
| Supplier Page | https://www.creativebiolabs.net/Pegvisomant-22439.htm |
| Additional Information | Pegvisomant is a growth hormone receptor antagonist used for the treatment of acromegaly. |